Regine Mayer‐Steinacker

Author

University Hospital Ulm

Also Known As

Ralf Ketter, Regine Mayer-Steinacker, Regine Mayer‐Steinacker

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University Hospital Ulm Heidelberg University University Hospital Heidelberg Universität Ulm University Medical Center Freiburg

About

Regine Mayer‐Steinacker is an author at University Hospital Ulm specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.6K
2	Health Sciences	2	2	148
3	Arts	1	1	34
4	Education	1	1	34
5	Nursing	1	1	34

Regine Mayer‐Steinacker

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Wolfgang Wick, Michael Platten, Christoph Meisner, The Lancet Oncology Neuro-oncologyTemozolomide ChemotherapyMalignant AstrocytomaRadiation TherapyMedicine	2012	1.1K
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, European Journal of Cancer	2019	700
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group Toshifumi Ozaki, Silke Flege, Matthias Kevric, Journal of Clinical Oncology	2003	341
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock, Journal of Clinical Oncology	2016	194
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide G. Dresemann, Michael Weller, Mark Rosenthal, Journal of Neuro-Oncology Neuro-oncologyOncologyMedicineGlioblastoma ResistantDose Temozolomide	2009	153
Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway Adrian von Witzleben, Lukas T. Goerttler, Ralf Marienfeld, Cancer Research	2015	93
Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study Catharina Silvia Lisson, Christoph Gerhard Lisson, Kerstin Flosdorf, European Radiology Medical ImagingMusculoskeletal ImagingHistopathologyPathologyMri-based 3D	2017	92
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07) Dagmar Beier, Martin Proescholdt, Christiane Reinert, Neuro-Oncology	2017	85
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials Merle Eselgrim, H Grunert, Thomas Kühne, Pediatric Blood & Cancer	2005	80
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma Antje Wick, Michael Platten, Christoph Meisner, Neuro-Oncology	2020	71

Page 1